Clincosm LogoSign in Get a demo

congenital adrenal hyperplasia

Showing 1 - 25 of 50
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia Trial (CRN04894)

Not yet recruiting
  • Congenital Adrenal Hyperplasia
  • Classic Congenital Adrenal Hyperplasia
  • (no location specified)
Jun 8, 2023

Congenital Adrenal Hyperplasia Trial run by the National Institutes of Health Clinical Center (CC) (virtual educational based

Not yet recruiting
  • Congenital Adrenal Hyperplasia
  • virtual educational based transition intervention self-paced
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Congenital Adrenal Hyperplasia Trial in United States (Abiraterone acetate, Placebo, Hydrocortisone)

Withdrawn
  • Congenital Adrenal Hyperplasia
  • Abiraterone acetate
  • +3 more
  • Los Angeles, California
  • +3 more
Jan 30, 2023

Baby Detect : Genomic Newborn Screening

Recruiting
  • Congenital Adrenal Hyperplasia
  • +126 more
    • Liege, Wallonia, Belgium
      CRMN, Hôpital La Citadelle
    Jan 24, 2023

    Congenital Adrenal Hyperplasia Trial in London (Lu AG13909)

    Recruiting
    • Congenital Adrenal Hyperplasia
    • Lu AG13909
    • London, England, United Kingdom
      University College London Hospital NHS Foundation Trust
    Dec 20, 2022

    Congenital Adrenal Hyperplasia Trial in Worldwide (Crinecerfont, Placebo)

    Recruiting
    • Congenital Adrenal Hyperplasia
    • Birmingham, Alabama
    • +45 more
    Dec 9, 2022

    Congenital Adrenal Hyperplasia Trial in Japan, United States (Chronocort, Cortef)

    Recruiting
    • Congenital Adrenal Hyperplasia
    • Orange, California
    • +21 more
    Nov 21, 2022

    Congenital Adrenal Hyperplasia Trial run by the (Hydrocortisone)

    Completed
    • Congenital Adrenal Hyperplasia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 17, 2022

    Congenital Adrenal Hyperplasia Trial in Worldwide (Tildacerfont/Placebo)

    Recruiting
    • Congenital Adrenal Hyperplasia
    • Tildacerfont/Placebo
    • Birmingham, Alabama
    • +56 more
    Sep 1, 2022

    Congenital Adrenal Hyperplasia Trial in United States (AAV BBP-631)

    Recruiting
    • Congenital Adrenal Hyperplasia
    • AAV BBP-631
    • Los Angeles, California
    • +6 more
    Jul 29, 2022

    Congenital Adrenal Hyperplasia Trial in Worldwide (Tildacerfont/Placebo)

    Recruiting
    • Congenital Adrenal Hyperplasia
    • Tildacerfont/Placebo
    • Birmingham, Alabama
    • +56 more
    Jul 19, 2022

    Congenital Adrenal Hyperplasia, 21-Hydroxylase Deficiency, Adrenogenital Syndrome Trial run by the (Chronocort, Cortef)

    Completed
    Has Results
    • Congenital Adrenal Hyperplasia
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 5, 2022

    Congenital Adrenal Hyperplasia Trial in Worldwide (Crinecerfont, Placebo)

    Recruiting
    • Congenital Adrenal Hyperplasia
    • Los Angeles, California
    • +62 more
    Apr 7, 2022

    Congenital Adrenal Hyperplasia Trial in Morehead City (Chronocort®, Standard Care)

    Withdrawn
    • Congenital Adrenal Hyperplasia
    • Morehead City, North Carolina
      Diabetes and Endocrinology Consultants PC
    Mar 31, 2022

    Congenital Adrenal Hyperplasia Trial run by the (Chronocort)

    Not yet recruiting
    • Congenital Adrenal Hyperplasia
    • Bethesda, Maryland
      National Institutes of Health Center
    Mar 18, 2022

    Congenital Adrenal Hyperplasia Trial in Naples (Conventional Glucocorticoids (immediate release hydrocortisone, cortisone

    Recruiting
    • Congenital Adrenal Hyperplasia
    • Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)
    • Dual release hydrocortisone (plenadren)
    • Naples, Italy
      Federico II University
    Mar 21, 2022

    Determine Eligibility for CAH-301 [NCT04783181])

    Recruiting
    • Congenital Adrenal Hyperplasia
    • Pre-Screening
    • Los Angeles, California
      Science37
    Mar 1, 2022

    Congenital Adrenal Hyperplasia Trial in United States (Abiraterone acetate)

    Active, not recruiting
    • Congenital Adrenal Hyperplasia
    • Abiraterone acetate
    • Los Angeles, California
    • +3 more
    Feb 22, 2022

    China Adrenal Disease Registry

    Recruiting
    • Cushing Syndrome
    • +7 more
      • Shanghai, China
        Endocrinology
      Jan 28, 2022

      Importance of Epinephrine/Adrenalin Deficiency in CAH

      Enrolling by invitation
      • Congenital Adrenal Hyperplasia
      • physical exercise as a standardized high intensity exercise test
      • Stress vulnerability
      • Stockholm, (State), Sweden
        Karolinska University hospital
      Dec 17, 2021

      Gonadal Changes In Congenital Adrenal Hyperplasia Patients

      Recruiting
      • Congenital Adrenal Hyperplasia
      • Ultrasonography and MRI
      • Cairo, Egypt
        Ain Shams University
      Dec 10, 2021

      Congenital Adrenal Hyperplasia Trial run by the (Chronocort®, standard glucocorticoid therapy)

      Completed
      Has Results
      • Congenital Adrenal Hyperplasia
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      May 4, 2021

      Congenital Adrenal Hyperplasia Trial in United States (ATR-101)

      Completed
      Has Results
      • Congenital Adrenal Hyperplasia
      • Baltimore, Maryland
      • +5 more
      Feb 16, 2021

      Congenital Adrenal Hyperplasia Trial in Worldwide (Nevanimibe HCl)

      Terminated
      Has Results
      • Congenital Adrenal Hyperplasia
      • Nevanimibe hydrochloride
      • Ribeirão Preto, Brazil
      • +10 more
      Feb 11, 2021

      Congenital Adrenal Hyperplasia Trial in Shanghai (Hydrocortisone, Prednisone, Dexamethasone)

      Unknown status
      • Congenital Adrenal Hyperplasia
      • Shanghai, Shanghai, China
        Ruijin hospital,Shanghai Jiao Tong University School of Medicine
      Aug 28, 2020